Results 11 to 20 of about 7,647 (148)

Montelucaste no Tratamento da Dermatite Atópica: Qual a Evidência? [PDF]

open access: yesGazeta Médica, 2023
A dermatite atópica é uma das doenças inflamatórias crónicas dermatológicas mais comuns. Ao longo dos anos tem surgido alguma evidência quanto ao envolvimento dos leucotrienos na fisiopatologia da dermatite atópica, existindo já relatos do uso do ...
Cristiana Soares   +2 more
doaj   +9 more sources

Dermatite atópica canina: Estudo de caso

open access: yesPubvet, 2018
A dermatite atópica canina é uma das dermatopatias alérgicas mais comuns em cães que tem origem genética e é de caráter inflamatório crônico, recorrente e demasiadamente pruriginosa.
Breno Henrique Alves   +9 more
doaj   +2 more sources

ERUPÇÃO VARICELIFORME DE KAPOSY EM UM PACIENTE COM DERMATITE ATÓPICA

open access: yesBrazilian Journal of Infectious Diseases, 2023
Introdução: A Erupção Variceliforme de Kaposy, denominada também como Eczema Herpético, é uma infecção que ocorre em pacientes com doenças dermatológicas prévias como Dermatite Atópica, Pênfigo Foliáceo, Doença de Darier, entre outras. O principal agente
Horley Soares Britto Neto   +4 more
doaj   +2 more sources

Effect of Gabapentin Administered With Prednisolone, Ciclosporin or a Placebo on Clinical Outcomes and Motor Activity in Cats With Atopic Skin Syndrome: A Prospective, Blinded, Placebo‐Controlled Study [PDF]

open access: yesVeterinary Dermatology, Volume 36, Issue 6, Page 814-824, December 2025.
Background: Gabapentin reportedly decreases central sensitisation, a disorder associated with chronic pruritus in humans, although this is not well documented in cats. Its combined use with the standard antipruritic therapy for feline atopic skin syndrome (FASS) is not yet described.
Jeanne Morency   +10 more
wiley   +2 more sources

Development of a Four‐Language Questionnaire to Investigate Environmental Risk Factors for the Development of Canine Atopic Dermatitis and to Monitor Disease Course and Progression [PDF]

open access: yesVeterinary Dermatology, Volume 37, Issue 1, Page 34-44, February 2026.
Background: The chronic and multifactorial character of canine atopic dermatitis (cAD) often leads to poor disease control and treatment dissatisfaction. Environmental factors are likely to contribute to the disease development and may play a more important role than assumed previously.
Patricia Clara‐Maria Rhodius   +11 more
wiley   +2 more sources

Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis [PDF]

open access: yesVeterinary Dermatology, Volume 36, Issue 2, Page 165-176, April 2025.
Background – Janus kinase inhibitors (JAKi) have been shown to reduce pruritus and improve associated inflammatory skin lesions in canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, in comparison to oclacitinib, for the control of cAD in a randomised, blinded trial.
Sophie Forster   +4 more
wiley   +2 more sources

Incidence Rate of Otitis Externa Episodes in Atopic Dogs Is Reduced by a Therapeutic Diet in a 6‐Month Randomised, Blinded, Controlled, Clinical Trial [PDF]

open access: yesVeterinary Dermatology, Volume 37, Issue 1, Page 89-102, February 2026.
ABSTRACT Background Recurrent otitis externa (OE) episodes commonly affect dogs with canine atopic dermatitis (cAD) despite ongoing cAD treatment. Objective To determine if a therapeutic diet with active ingredients targeting the skin barrier and allergy pathways reduces the incidence rate of OE.
Adrian Watson   +5 more
wiley   +2 more sources

Immunotherapy using pullulan‐conjugated Der f 2 allergen in canine atopic dermatitis: An anti‐inflammatory agent‐sparing approach [PDF]

open access: yesVeterinary Dermatology, Volume 36, Issue 4, Page 443-452, August 2025.
Background – Allergen immunotherapy is used as aetiological treatment for canine atopic dermatitis (cAD). Objective – To assess the anti‐inflammatory agent‐sparing effect over 1 year of immunotherapy using pullulan‐conjugated recombinant Der f 2 (rDf2‐P). Conclusions and Clinical Relevance – Der f 2‐P immunotherapy can lead to a rapid reduction in anti‐
Masahiko Nagata   +7 more
wiley   +2 more sources

O PAPEL DO OMALIZUMAB NA DERMATITE ATÓPICA GRAVE [PDF]

open access: yesRevista da Sociedade Portuguesa de Dermatologia e Venereologia, 2011
Apresentam-se os casos de duas jovens, com diagnóstico de dermatite atópica grave medicadas com anti-histamínicos orais, corticóides tópicos, ciclos de corticoterapia sistémica em doses elevadas e/ou ciclosporina oral, sem melhoria e com agravamento ...
Sofia Luz   +5 more
doaj   +2 more sources

An open‐label pilot study on an adsorbent mousse containing adelmidrol in client‐owned cats with feline atopic skin syndrome and associated seborrhoea [PDF]

open access: yesVeterinary Dermatology, Volume 36, Issue 5, Page 638-646, October 2025.
Background – Besides pruritus and skin lesions, cats with feline atopic skin syndrome (FASS) may have seborrhoea. Hypothesis/Objectives – The aim of this pilot study was to investigate whether an adsorbent mousse containing tapioca starch, adelmidrol and a nonpharmacological antimicrobial complex could decrease FASS‐associated seborrhoea in cats ...
Chiara Noli   +4 more
wiley   +2 more sources

Home - About - Disclaimer - Privacy